• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Glia Microglia Influence Host Defense, Disease, and Repair Following Murine Coronavirus Infection of the Central Nervous System

tetano

Editor, Senior Moderator
Glia


. 2020 May 25.
doi: 10.1002/glia.23844. Online ahead of print.
Microglia Influence Host Defense, Disease, and Repair Following Murine Coronavirus Infection of the Central Nervous System


Vrushali Mangale[SUP] 1 [/SUP], Amber R Syage[SUP] 2 [/SUP], H Atakan Ekiz[SUP] 1 [/SUP], Dominic D Skinner[SUP] 1 [/SUP], Yuting Cheng[SUP] 2 [/SUP], Colleen L Stone[SUP] 1 [/SUP], R Marshall Brown[SUP] 1 [/SUP], Ryan M O'Connell[SUP] 1 [/SUP], Kim N Green[SUP] 2 [/SUP], Thomas E Lane[SUP] 2 [/SUP]



Affiliations

Abstract

The present study examines functional contributions of microglia in host defense, demyelination, and remyelination following infection of susceptible mice with a neurotropic coronavirus. Treatment with PLX5622, an inhibitor of colony stimulating factor 1 receptor (CSF1R) that efficiently depletes microglia, prior to infection of the central nervous system (CNS) with the neurotropic JHM strain of mouse hepatitis virus (JHMV) resulted in increased mortality compared with control mice that correlated with impaired control of viral replication. Single cell RNA sequencing (scRNASeq) of CD45+ cells isolated from the CNS revealed that PLX5622 treatment resulted in muted CD4+ T cell activation profile that was associated with decreased expression of transcripts encoding MHC class II and CD86 in macrophages but not dendritic cells. Evaluation of spinal cord demyelination revealed a marked increase in white matter damage in PLX5622-treated mice that corresponded with elevated expression of transcripts encoding disease-associated proteins Osteopontin (Spp1), Apolipoprotein E (Apoe), and Triggering receptor expressed on myeloid cells 2 (Trem2) that were enriched within macrophages. In addition, PLX5622 treatment dampened expression of Cystatin F (Cst7), Insulin growth factor 1 (Igf1), and lipoprotein lipase (Lpl) within macrophage populations which have been implicated in promoting repair of damaged nerve tissue and this was associated with impaired remyelination. Collectively, these findings argue that microglia tailor the CNS microenvironment to enhance control of coronavirus replication as well as dampen the severity of demyelination and influence repair.

Keywords: coronavirus; demyelination; host defense; microglia; remyelination.
 
Back
Top